Immediate Impact

1 by Nobel laureates 7 from Science/Nature 59 standout
Sub-graph 1 of 23

Citing Papers

Emerging therapies in cancer metabolism
2023 Standout
Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort
2023 Standout
2 intermediate papers

Works of Alison M. Friedmann being referenced

Outstanding Outcome for Children with Standard Risk-Low (SR-Low) Acute Lymphoblastic Leukemia (ALL) and No Benefit to Intensified Peg-Asparaginase (PEG-ASNase) Therapy: Results of Children’s Oncology Group (COG) Study AALL0331
2014
Association Between Radiotherapy vs No Radiotherapy Based on Early Response to VAMP Chemotherapy and Survival Among Children With Favorable-Risk Hodgkin Lymphoma
2012

Author Peers

Author Last Decade Papers Cites
Alison M. Friedmann 513 291 311 56 1.3k
Paolo Tamaro 342 238 218 55 1.0k
Demetrius Traggis 761 293 238 40 1.7k
Brian Greffe 333 198 195 42 1.2k
Arthur J. Provisor 586 208 162 40 1.7k
Christine Mauz‐Körholz 310 273 633 86 1.4k
Erin Morris 372 243 329 61 1.2k
Purna Kurkure 373 205 100 90 1.2k
François Deméocq 223 214 104 42 1.1k
Ananth Shankar 327 142 529 71 1.4k
F Deméocq 192 405 225 75 1.5k

All Works

Loading papers...

Rankless by CCL
2026